-
Posted by
Two Blokes Fri at 8:15 AM -
Filed in
Stock
-
2 views
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has topped up its coffers with a £500,000 share subscription to support its proof-of-concept trial. It is issuing 62.5 million new shares, priced at 0.8p per share.
